Cargando…
Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial Carcinoma
We set out to expand on our previous work in which we reported the epithelial expression pattern of a urine-based bladder cancer-associated diagnostic panel (A1AT, ANG, APOE, CA9, IL8, MMP9, MMP10, PAI1, SDC1, and VEGFA). Since many of the analytes in the bladder cancer-associated diagnostic signatu...
Autores principales: | Furuya, Hideki, Chan, Owen T.M., Hokutan, Kanani, Tsukikawa, Yutaro, Chee, Keanu, Kozai, Landon, Chan, Keith S., Dai, Yunfeng, Wong, Regan S., Rosser, Charles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168167/ https://www.ncbi.nlm.nih.gov/pubmed/31905599 http://dx.doi.org/10.3390/diagnostics10010014 |
Ejemplares similares
-
Plasminogen activator inhibitor-2
(PAI-2) overexpression supports
bladder cancer development
in PAI-1 knockout mice in N-butyl-N-
(4-hydroxybutyl)-nitrosamine- induced bladder
cancer mouse model
por: Furuya, Hideki, et al.
Publicado: (2020) -
Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation
por: Peres, Rafael, et al.
Publicado: (2016) -
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
por: Chan, Owen T.M., et al.
Publicado: (2017) -
Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model
por: Furuya, Hideki, et al.
Publicado: (2019) -
Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
por: Miyake, Makito, et al.
Publicado: (2019)